Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $768.9200 (-0.28%) ($762.6700 - $768.9200) on Thu. Mar. 2, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.71% (three month average) | RSI | 63 | Latest Price | $768.9200(-0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(42%) DIA(32%) VYM(29%) SPLV(27%) | Factors Impacting REGN price | REGN will decline at least -0.855% in a week (0% probabilities). VIXM(-13%) VXX(-8%) UUP(-4%) TBT(-3%) ARKK(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.855% (StdDev 1.71%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $762.93(0.79%) | 10 Day Moving Average | $755.86(1.73%) | 20 Day Moving Average | $757.68(1.48%) | To recent high | -2% | To recent low | 13% | Market Cap | $81.528b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |